- Grants since 2016
- 484
- Awarded, last 5 years (where amounts are published)
- 57M
- Funded works, last 5 years
- 437
- Funded works, all time
- 2 006
Grants
2023–2025 · award
Empowering users for on-demand use of a speech neuroprosthesis
David Brandman · University of California System
2023 · award
Axonal TDP-43 dysfunction as a pathogenic event in ALS
Christopher Donnelly · University of Pittsburgh
2023–2024 · award
Characterization of a human model of the cortico-motor system to study ALS
Jimena Andersen · Emory University
2023–2024 · award
A novel combination approach to ALS
Kim Staats · Raya Therapeutic, Inc
2023–2026 · award
Increasing ALS clinical trial capacity at University of Michigan
Stephen Goutman · Regent University
2023–2024 · award
Developing a miniCas-based system to target C9orf72 repeat expansion toxicity
Qiang Zhu · Van Andel Institute
2023–2024 · award
A competitive synapto-forming assay to study sporadic ALS using hiPSCs
Vladimir Zhemkov · Cedars-Sinai Medical Center
2023–2024 · award
Unraveling RNA Modifications in ALS Blood through Nanopore Direct RNA Sequencing
Yue Zhao · Regent University
2023–2024 · award
Implementation of a Transcutaneous CO2 Monitoring Protocol in ALS
Jason Ackrivo · Pennsylvania State University
2023–2026 · award
Rocky Mountain ALS trials: underserved & genetic population optimization
Laura Foster · University Of Colorado Denver, Amc And Dc
2023–2024 · award
ALS-linked U7 snRNA mislocalization leads to retrotransposon activation
Katarzyna Raczynska · Adam Mickiewicz University in Poznań
2023–2025 · award
ALS FOCUS Program, Surveys, Maintenance, and Support
Alexander Sherman · Massachusetts General Hospital
2023–2025 · award
Joint Research Funding for ALS Association & Focused Ultrasound Foundation
Emily White · Focused Ultrasound Foundation
2023–2027 · award
Caribbean Hispanic Amyotrophic Lateral Sclerosis Center for Clinical Trials
Valerie Wojna · University of Puerto Rico, Medical Sciences Campus
2023–2024 · award
Gene-environment interactions for predicting onset of clinically manifest ALS
Michael Benatar · University of Miami
2023–2025 · award
2023 Clinical Research Training Scholarship
Marina Avetisyan · Massachusetts General Hospital
2023–2025 · award
Efficacy and preclinical characterization of a HDAC6 inhibitor (ORY-4001) in ALS
Jordi Xaus · Oryzon Genomics (Spain)
2023–2026 · award
Ohio State ALS Clinical Trial Access and Capacity Leadership
Stephen Kolb · The Ohio State University
2023–2024 · award
PREVENT ALS: a multi-site longitudinal study of at-risk ALS mutation carriers
Matthew Harms · Columbia University
2023–2025 · award
Novel suppressors of neurodegeneration in sod-1 G85R models
Alexander Lin-Moore · Brown University
2023 · award
Analyzing the cerebrovascular changes in patients with ALS
Richard Daneman · University of San Diego
2023–2024 · award
Defining the ALS exposome in at risk individuals to guide ALS prevention efforts
Stephen Goutman · Regent University
2023–2024 · award
2023 Sheila Essey Award for ALS Research
Virginia Lee · University of Pennsylvania
2023–2025 · award
A phase 1c study of prosetin, a brain-penetrant MAP4Ki, in people with ALS
Erin Fleming · Projenx, Inc.
2023–2025 · award
Targeting the neuroinflammatory component of ALS using CSF1R inhibitors
Michael Young · Myrobalan Therapeutics
2022–2023 · award
RAPA-501 Hybrid TREG/Th2 Cell Therapy of ALS
Daniel Fowler · Rapt Therapeutics (United States)
2022–2024 · award
2022 Clinical Research Training Scholarship
Sanjana Shellikeri · University of Pennsylvania
2022–2026 · award
Increasing trial accessibility in underserved populations
Jeffrey Statland · University of Kansas Medical Center
2022–2025 · award
2022 Clinician Scientist Development Award
Frederick Arnold · University of California, Irvine
2022–2026 · award
Enhancement of Trial Capacity at Temple University ALS Center of Hope
Terry Heiman-Patterson · Temple University
2022–2023 · award
A brain-computer interface for restoring speech in people with ALS
Sergey Stavisky · University of California System
2022–2024 · award
Establishing causative roles for SARM1 coding & expression level variants in ALS
Jemeen Sreedharan · University of Cambridge
2022–2023 · award
An Integrated Genome-Based Approach to Individualised Treatment in ALS and FTD
Ahmad Al Khleifat · King's College London
2022–2025 · award
ALSUntangled
Richard Bedlack · Duke Medical Center
2022–2023 · award
To investigate the relationship between exposure to tropical infections and ALS
Nortina Shahrizaila · University of Malaya
2022–2024 · award
TRPML1 small molecule agonists for the treatment of ALS
Martin Gill · Libra Therapeutics, Inc.
2022–2024 · award
Acute adenosine receptor antagonism to promote breathing plasticity in ALS
Barbara Smith · University of Florida
2022–2023 · award
Establishing an African ALS-research network to transform the ALS landscape
Jeannine Heckmann · Aga Khan University Nairobi
2022–2024 · award
Shining a light on the dark proteome: investigating retroelements in ALS
Alexandra Whiteley · University of Colorado Boulder
2022–2023 · award
Maintain the SOD1 breeding colony in 2022
Julie Torvund-Jensen · Taconic Biosciences, Inc.
